Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS

Beneficial Ownership Report · SCHEDULE 13G

Arcadia Biosciences, Inc.

RKDANASDAQEQUITYCurrent

Beneficial Ownership Report

Filed Sep 30, 2026Accepted Sep 30, 2026, 8:26 AM EDTFiling CIK 2103370Accession 0002103370-26-000004
Share

Structured filing — SCHEDULE 13G

primary_doc.xml

Open full document ↗

Subject company

Company
Arcadia Biosciences, Inc.
Company CIK
0001469443
Street
5956 SHERRY LANE
Street (continued)
SUITE 2000
City
DALLAS
State / country code
TX
Postal code
75225

Statement details

Security class
Common
Event date
09/25/2026
Rule designation
Rule 13d-1(c)

Reporting person 1

Name
MJL Manager LLC
Citizenship / organization
X1
Reporting person type
IA
Group designation
b
Aggregate amount owned
378,740.00
Percent of class
15.7
Sole voting power
0.00
Shared voting power
378,740.00
Sole dispositive power
0.00
Shared dispositive power
378,740.00
Comments
MJL Manager LLC ("MJL") is the general partner of Capuchin Capital Fund LP.

Reporting person 2

Name
Michael Liu
Citizenship / organization
X1
Reporting person type
IN
Group designation
b
Aggregate amount owned
378,740.00
Percent of class
15.7
Sole voting power
0.00
Shared voting power
378,740.00
Sole dispositive power
0.00
Shared dispositive power
378,740.00
Comments
Michael Liu is the sole control person of MJL and, in such capacity, has the authority to direct the voting and disposition of the shares held by Capuchin Capital Fund LP. The reporting of shared power by the reporting persons shall not be construed as an admission that they are the beneficial owner of shares beneficially owned by the other, and each expressly disclaims beneficial ownership except to the extent of such person's actual pecuniary interest therein.

Reporting person 3

Name
Capuchin Capital Fund LP
Citizenship / organization
X1
Reporting person type
PN
Group designation
b
Aggregate amount owned
378,740.00
Percent of class
15.7
Sole voting power
0.00
Shared voting power
378,740.00
Sole dispositive power
0.00
Shared dispositive power
378,740.00

Item 1

Issuer

Arcadia Biosciences, Inc.

Principal executive office address

5956 SHERRY LANE, SUITE 2000, DALLAS, TEXAS, 75225

Item 2

Citizenship

MJL Manager LLC - New Jersey Michael Liu - USA Capuchin Capital Fund LP - Delaware

Filing person

MJL Manager LLC Michael Liu Capuchin Capital Fund LP

Principal business or residence address

12 Manley Road, Pennington NJ 08534

Item 3

Not applicable indication

Y

Item 4

Percent of class

15.7%, calculated based on 2,409,211 total shares outstanding as reported by the issuer in its Form 10-Q filed August 13th, 2026

Amount beneficially owned

378,740

Sole voting power

0

Shared voting power

378,740

Sole dispositive power

0

Shared dispositive power

378,740

Item 5

Not applicable indication

Y

Ownership of 5% or less

N

Item 6

Not applicable indication

Y

Item 7

Not applicable indication

Y

Item 8

Not applicable indication

N

Group members

See Item 2(a) in lieu of an Exhibit.

Item 9

Not applicable indication

Y

Item 10

Not applicable indication

N

Certifications

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

Exhibits

Exhibit I - JOINT FILING STATEMENT

Signature 1

Reporting person
MJL Manager LLC
Signed
Michael Liu
Title
Managing Member
Date
09/30/2026

Signature 2

Reporting person
Michael Liu
Signed
Michael Liu
Title
Individual
Date
09/30/2026

Signature 3

Reporting person
Capuchin Capital Fund LP
Signed
Michael Liu
Title
Managing Member
Date
09/30/2026

Filed exhibits

Company context

Since 2002, Arcadia Biosciences (Nasdaq: RKDA) has been innovating high-value, healthy ingredients to meet consumer demands for healthier choices. With its roots in agricultural innovation, Arcadia cultivates next-generation wellness products. For more information, visit www.arcadiabio.com.

Current securities

Recent company filings

  1. S-8 filingSep 30, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security HoldersSep 15, 2026
  3. 4 filingSep 14, 2026
  4. 4 filingSep 14, 2026
  5. 4 filingSep 14, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.